A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Completed

Plain-English translation of NCT03089944 on ClinicalTrials.gov ↗ · Source last updated July 2020 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(113 sites)

United States

St. Josephs Hosp and Med Ctr /ID# 162762, Phoenix, Arizona

Mayo Clinic Arizona /ID# 162314, Phoenix, Arizona

Liver Wellness Center /ID# 162244, Little Rock, Arkansas

Felizarta /ID# 162295, Bakersfield, California

VA Long Beach Healthcare System /ID# 162298, Long Beach, California